Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash-Reference-Cited by-同舟云学术

Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash

Published:2016-08-03 Issue:5 Volume:24 Page:283-285
ISSN:2047-9956
Container-title:European Journal of Hospital Pharmacy
language:en
Short-container-title:Eur J Hosp Pharm

Author:

Usui Naoko,Kondo Yoko,Ryota Noriko,Suzuki Hidekazu,Okamoto Norio,Sando Masumi,Tani Eriko,Hamaguchi Masanari,Tanaka Ayako,Tamiya Motohiro,Shiroyama Takayuki,Morishita Naoko,Tanaka Emiko,Hirashima Tomonori

Publisher

BMJ

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference12 articles.

1. PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer;Paz-Ares;J Clin Oncol,2013

2. Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial;Barlesi;Ann Oncol,2014

3. A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer;Dreicer;Invest New Drugs,2013

4. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

5. Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer;Clarke;Ann Oncol,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel anticancers and dermatological adversities: old rivals but new challenges;BMJ Case Reports;2018-12